Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Papagalloon Aug 31, 2015 4:35pm

230 Views

Post# 24066327

Any idea for the delay?

Been a shareholder here for awhile and not sure if this has been answered. Has anyone spoken to the company regarding the reason for the delay of the 2000? Is Health Canada possibly concerned about the health claims or efficacy of the new model (hopefully not) or simply delaying due to volume of work? If it's the former, then there is a serious problem here...if the latter, Health Canada is causing untold damage, both financial and physical to patients that are being deprived of proper care.

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property